[{"data":1,"prerenderedAt":212},["ShallowReactive",2],{"blog-\u002Fblog\u002Fpeptides-what-the-evidence-actually-shows":3},{"id":4,"title":5,"body":6,"category":187,"date":188,"description":189,"editor":190,"enable_toc":191,"extension":192,"image":193,"keywords":194,"meta":204,"navigation":191,"path":205,"published":191,"seo":206,"stem":207,"tags":208,"__hash__":211},"blog\u002Fblog\u002Fpeptides-what-the-evidence-actually-shows.md","Peptides: What the Evidence Actually Shows",{"type":7,"value":8,"toc":177},"minimark",[9,13,17,20,23,28,31,34,43,45,49,52,65,67,71,79,81,85,88,91,94,96,100,103,111,113,117],[10,11,5],"h1",{"id":12},"peptides-what-the-evidence-actually-shows",[14,15,16],"p",{},"Somewhere between your podcast feed and your gym's group chat, \"peptides\" became a category you are apparently supposed to have an opinion about. The word gets used for everything from a drug your cardiologist can prescribe to a vial of white powder that arrived from an overseas website labeled \"for research use only.\" Those two things have nothing in common except chemistry — and the chemistry is the least important part.",[14,18,19],{},"A peptide is just a short chain of amino acids — a protein fragment. Insulin is a peptide. So is the collagen in your coffee. So is BPC-157. Calling something a peptide tells you what it is made of, not whether it works, and the marketing leans hard on that ambiguity: the halo of the peptides that are real medicine gets borrowed by the ones that have never been through a human trial. So instead of asking \"do peptides work?\", sort them into tiers by the only thing that matters — what has actually been tested in people.",[21,22],"br",{},[24,25,27],"h2",{"id":26},"tier-one-the-peptides-that-are-actual-medicine","Tier one: the peptides that are actual medicine",[14,29,30],{},"The most effective weight-loss drugs in history are peptides. Semaglutide — a GLP-1 receptor agonist — produced roughly 15% body-weight loss over 68 weeks in its landmark trial (Wilding et al., 2021), a result no supplement has ever approached. Its successor trials went further: in adults with obesity and cardiovascular disease, semaglutide reduced major cardiac events by 20% (Lincoff et al., 2023). This is what strong evidence looks like — tens of thousands of participants, randomized, placebo-controlled, published in the world's most scrutinized journals, with regulators reviewing every data point.",[14,32,33],{},"Notice what else is true about them: they are prescription drugs. You get them through a physician who screens you, doses you, and monitors you — because they are potent enough to need all three. That is not a bug in the system. Potency and oversight travel together, and the entire pitch of gray-market peptides is that you can have the first without the second.",[14,35,36,37,42],{},"If GLP-1s are on your radar, the conversation to have is with your doctor, ideally armed with your actual numbers — your ",[38,39,41],"a",{"href":40},"\u002Fresources\u002Fcalculators\u002Fascvd","10-year cardiovascular risk"," is a better opener than anything you heard on a podcast.",[21,44],{},[24,46,48],{"id":47},"tier-two-collagen-the-boring-peptide-that-mostly-holds-up","Tier two: collagen — the boring peptide that mostly holds up",[14,50,51],{},"Collagen peptides are the opposite end of the risk spectrum: hydrolyzed protein fragments from connective tissue, sold as powder, consumed as food. The evidence is modest and reasonably honest. Trials show improved skin elasticity and hydration over 8 weeks (Proksch et al., 2014), reduced activity-related joint pain in athletes over 24 weeks (Clark et al., 2008), and — combined with resistance training — better body composition in elderly men with sarcopenia (Zdzieblik et al., 2015).",[14,53,54,55,59,60,64],{},"The catch is what collagen is not. As a muscle-building protein it is second-rate: collagen is low in leucine and essentially devoid of tryptophan, which makes it an incomplete protein and a poor substitute for whey or food protein where ",[38,56,58],{"href":57},"\u002Fblog\u002Fprotein-for-muscle-growth","muscle growth"," is the goal. Treat it as a possible add-on for joints and skin with a tolerable price and near-zero risk — not as a scoop that counts meaningfully toward your ",[38,61,63],{"href":62},"\u002Fresources\u002Fcalculators\u002Fprotein","daily protein target",".",[21,66],{},[24,68,70],{"id":69},"the-control-group-what-good-supplement-evidence-looks-like","The control group: what good supplement evidence looks like",[14,72,73,74,78],{},"Before we get to the gray market, calibrate on creatine — not a peptide, but the standard every performance compound should be measured against. Hundreds of randomized trials, an international position stand (Kreider et al., 2017), decades of safety data, effects large enough to survive every replication attempt, and dosing so settled you can ",[38,75,77],{"href":76},"\u002Fresources\u002Fcalculators\u002Fcreatine-dose","compute it from your body weight",". That is the bar. It exists, it is cheap, and it is legal — which is worth remembering when someone offers you something with none of those properties.",[21,80],{},[24,82,84],{"id":83},"tier-three-the-gray-market","Tier three: the gray market",[14,86,87],{},"Now the vials. BPC-157, TB-500, ipamorelin, CJC-1295 — the compounds that dominate peptide content online share a profile: promising results in rodents, mechanistic stories that sound plausible, and essentially no published randomized human trials. BPC-157, the most famous, has healed rat tendons, rat ulcers, and rat nerve injuries in dozens of studies. The number of published placebo-controlled human trials is zero. Every dosing protocol you have seen for it was extrapolated from rodents by someone on a forum.",[14,89,90],{},"The institutional signals all point the same direction. WADA prohibits BPC-157 and the growth-hormone secretagogues for athletes (World Anti-Doping Agency, 2026). The FDA has placed several of these compounds — BPC-157 and CJC-1295 among them — in the category of bulk substances that may present significant safety risks when compounded, citing the absence of human safety data (FDA, 2023). And because the products are sold as \"research chemicals\" outside any drug-manufacturing oversight, the vial's actual contents, purity, and sterility are whatever the seller says they are. Independent testing of gray-market peptide products has repeatedly found mislabeled doses and contaminated samples — a meaningful problem for something people inject.",[14,92,93],{},"None of this proves BPC-157 does nothing in humans. Rodent wound-healing data is genuinely interesting, and someday someone may fund the trial. But \"interesting in rats, untested in people, banned in sport, flagged by regulators, sold without quality control\" is a specific risk profile — and it is the profile of every compound in this tier. You will find no dosing guidance for them here, because there is no human evidence from which honest dosing guidance could come.",[21,95],{},[24,97,99],{"id":98},"how-to-use-the-word-peptide-from-now-on","How to use the word \"peptide\" from now on",[14,101,102],{},"Strip the category word away and ask three questions instead. Has it been tested in humans, randomized and controlled? Is someone accountable for what is actually in the vial or the tub? And does the person recommending it profit from the answer? GLP-1s pass all three — through a prescription pad. Collagen passes two and is honest about its ceiling. The research-chemical tier fails all three, and its entire marketing model depends on you not asking.",[14,104,105,106,110],{},"The supplement world already has compounds that pass the bar — we grade the major ones, citations included, in the ",[38,107,109],{"href":108},"\u002Fresources\u002Fsupplements","supplements guide",". The pattern that emerges there applies doubly here: the products with the loudest promises and the least oversight are almost never the ones with the evidence. Your tendons may eventually get a peptide that works. Until the human trials exist, the strongest thing you can inject into your training is consistency.",[21,112],{},[24,114,116],{"id":115},"references","References",[118,119,120,129,135,142,149,156,163,170],"ol",{},[121,122,123,124,128],"li",{},"Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). \"Once-weekly semaglutide in adults with overweight or obesity.\" ",[125,126,127],"em",{},"New England Journal of Medicine",", 384(11), 989-1002.",[121,130,131,132,134],{},"Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., et al. (2023). \"Semaglutide and cardiovascular outcomes in obesity without diabetes.\" ",[125,133,127],{},", 389(24), 2221-2232.",[121,136,137,138,141],{},"Proksch, E., Segger, D., Degwert, J., et al. (2014). \"Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study.\" ",[125,139,140],{},"Skin Pharmacology and Physiology",", 27(1), 47-55.",[121,143,144,145,148],{},"Clark, K. L., Sebastianelli, W., Flechsenhar, K. R., et al. (2008). \"24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain.\" ",[125,146,147],{},"Current Medical Research and Opinion",", 24(5), 1485-1496.",[121,150,151,152,155],{},"Zdzieblik, D., Oesser, S., Baumstark, M. W., et al. (2015). \"Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men: a randomised controlled trial.\" ",[125,153,154],{},"British Journal of Nutrition",", 114(8), 1237-1245.",[121,157,158,159,162],{},"Kreider, R. B., Kalman, D. S., Antonio, J., et al. (2017). \"International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine.\" ",[125,160,161],{},"Journal of the International Society of Sports Nutrition",", 14, 18.",[121,164,165,166,169],{},"World Anti-Doping Agency. (2026). \"The Prohibited List.\" ",[125,167,168],{},"World Anti-Doping Agency",", S0\u002FS2 categories.",[121,171,172,173,176],{},"U.S. Food and Drug Administration. (2023). \"Certain bulk drug substances for use in compounding that may present significant safety risks.\" ",[125,174,175],{},"FDA Human Drug Compounding",", Category 2 listing.",{"title":178,"searchDepth":179,"depth":179,"links":180},"",2,[181,182,183,184,185,186],{"id":26,"depth":179,"text":27},{"id":47,"depth":179,"text":48},{"id":69,"depth":179,"text":70},{"id":83,"depth":179,"text":84},{"id":98,"depth":179,"text":99},{"id":115,"depth":179,"text":116},"nutrition","2026-08-26","GLP-1s are peptides. So is the gray-market vial your gym friend injects. The word covers prescription medicine with landmark trials and compounds that have never seen a human study — here is how to tell which is which.","JD",true,"md","\u002Fimages\u002Fblog\u002Fhand_of_pills.jpg",[195,196,197,198,199,200,201,202,203],"peptides","BPC-157","collagen peptides","GLP-1","semaglutide","ipamorelin","TB-500","peptide therapy","peptide evidence",{},"\u002Fblog\u002Fpeptides-what-the-evidence-actually-shows",{"title":5,"description":189},"blog\u002Fpeptides-what-the-evidence-actually-shows",[209,195,210],"supplements","evidence","z0U2rshlR0YqWl1O0BOT3xBD8ZlftSjeDBUjTaaJ7bM",1787802831171]